Literature DB >> 25068564

Defining the residual risk of adverse perinatal outcome in growth-restricted fetuses with normal umbilical artery blood flow.

Vicky O'Dwyer1, Gerard Burke2, Julia Unterscheider3, Sean Daly4, Michael P Geary5, Mairead M Kennelly6, Fionnuala M McAuliffe7, Keelin O'Donoghue8, Alyson Hunter9, John J Morrison10, Patrick Dicker11, Elizabeth C Tully3, Fergal D Malone3.   

Abstract

OBJECTIVE: We sought to determine the cause of adverse perinatal outcome in fetal growth restriction (FGR) where umbilical artery (UA) Doppler was normal, as identified from the Prospective Observational Trial to Optimize Pediatric Health (PORTO). We compared cases of adverse outcome where UA Doppler was normal and abnormal. STUDY
DESIGN: The PORTO study was a national multicenter study of >1100 ultrasound-dated singleton pregnancies with an estimated fetal weight <10th centile. Each pregnancy underwent intensive ultrasound, including multivessel Doppler. UA Doppler was considered abnormal when the pulsatility index was >95th centile or end-diastolic flow was absent/reversed. Adverse perinatal outcome was defined as a composite of intraventricular hemorrhage, periventricular leukomalacia, hypoxic ischemic encephalopathy, necrotizing enterocolitis, bronchopulmonary dysplasia, sepsis, or death.
RESULTS: In all, 57 (5.0%) of the 1116 fetuses had an adverse perinatal outcome. Nine (1.3%) of 698 fetuses with normal UA Doppler had an adverse outcome, compared with 48 (11.5%) of 418 with abnormal UA Doppler (P < .0001). There were 2 perinatal deaths in the normal group and 6 in the abnormal group (P = .01). The perinatal deaths in the normal group were 1 case of pulmonary hypoplasia after prolonged preterm rupture of the membranes from 12 weeks' gestation and a case of placental abruption. Gestation at delivery was 33 ± 3 vs 31 ± 4 weeks (P = .05) and mean birthweight was 1830 ± 737 vs 1146 ± 508 g (P = .001) in the respective groups. Neonatal sepsis was the commonest adverse outcome in both groups: 0.1% and 0.4%, respectively (P = .01).
CONCLUSION: Adverse perinatal outcome is uncommon in FGR with normal UA Doppler. The cases we identified were associated with heterogenous pathologies. FGR with normal UA blood flow is a largely benign condition.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  adverse perinatal outcome; fetal growth restriction; umbilical artery Doppler

Mesh:

Year:  2014        PMID: 25068564     DOI: 10.1016/j.ajog.2014.07.033

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Quantitative longitudinal T2* mapping for assessing placental function and association with adverse pregnancy outcomes across gestation.

Authors:  Matthias C Schabel; Victoria H J Roberts; Karen J Gibbins; Monica Rincon; Jessica E Gaffney; Aaron D Streblow; Adam M Wright; Jamie O Lo; Byung Park; Christopher D Kroenke; Kathryn Szczotka; Nathan R Blue; Jessica M Page; Kathy Harvey; Michael W Varner; Robert M Silver; Antonio E Frias
Journal:  PLoS One       Date:  2022-07-19       Impact factor: 3.752

2.  Risk evaluation of fetal growth restriction by combined screening in early and mid-pregnancy.

Authors:  Bo Wang; Chunhua Zhang
Journal:  Pak J Med Sci       Date:  2020 Nov-Dec       Impact factor: 1.088

3.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy E Whitten; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2016

Review 4.  Obstetric management, tests, and technologies that impact childhood development.

Authors:  Christopher M Novak; Ernest M Graham
Journal:  Dev Med Child Neurol       Date:  2019-01-28       Impact factor: 5.449

5.  Perinatal outcomes after intrauterine growth restriction and umbilical artery Doppler pulsatility index of less than the fifth percentile.

Authors:  Adam K Lewkowitz; Methodius G Tuuli; Alison G Cahill; George A Macones; Jeffrey M Dicke
Journal:  J Matern Fetal Neonatal Med       Date:  2019-05-15

6.  Advantages of the Quadruple Screen over noninvasive prenatal testing.

Authors:  Nathan A Keller; Asha Rijshinghani
Journal:  Clin Case Rep       Date:  2016-01-18

Review 7.  A review of fetal cardiac monitoring, with a focus on low- and middle-income countries.

Authors:  Camilo E Valderrama; Nasim Ketabi; Faezeh Marzbanrad; Peter Rohloff; Gari D Clifford
Journal:  Physiol Meas       Date:  2020-12-18       Impact factor: 2.688

8.  Introducing a Mobile-Connected Umbilical Doppler Device (UmbiFlow™) into a Primary Care Maternity Setting: Does This Reduce Unnecessary Referrals to Specialised Care? Results of a Pilot Study in Kraaifontein, South Africa.

Authors:  Josef Mufenda; Stefan Gebhardt; Rita van Rooyen; Gerhard Theron
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

9.  Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016).

Authors:  Sven Kehl; Jörg Dötsch; Kurt Hecher; Dietmar Schlembach; Dagmar Schmitz; Holger Stepan; Ulrich Gembruch
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-11-27       Impact factor: 2.915

10.  Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  Sarah Rae Easter; Linda O Eckert; Nansi Boghossian; Rebecca Spencer; Eugene Oteng-Ntim; Christos Ioannou; Manasi Patwardhan; Margo S Harrison; Asma Khalil; Michael Gravett; Robert Goldenberg; Alastair McKelvey; Manish Gupta; Vitali Pool; Stephen C Robson; Jyoti Joshi; Sonali Kochhar; Tom McElrath
Journal:  Vaccine       Date:  2017-12-04       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.